Page 10 - Development Command News Today

Since its enactment in 2017, Public Law No. 115-92 has significantly boosted the availability of medical products that protect and treat military personnel. Designed to overcome the...

Non-Dilutive Funding to Accelerate Development of Artificial Intelligence Driven Handheld DeepView® ... | April 18, 2023

Astrocyte Pharmaceuticals Inc. announced initiation of a phase 1b study of AST-004, a small molecule adenosine A3/A1 receptor agonist for stroke and traumatic brain injuries that will be evaluated in healthy volunteers.According to a release from Astrocyte, the study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AST-004 as a loading dose followed by continuous

The Multi-Domain Operations Radar for Air-Launched Effects (ALE) has entered the competitive phase of the acquisition process.

San Antonio, TX (PRWEB) March 16, 2023 -- Prytime Medical Inc, The REBOA Company™, the leading innovator and global provider of lifesaving REBOA products for

The Pentagon continues its research even after US spies found no signs of foreign high-tech energy weapon The Pentagon must shut down its

The Pentagon continues its research even after US spies found no signs of foreign high-tech energy weapon Animal advocacy group PETA has u

People for the Ethical Treatment of Animals is urging the Pentagon to ban all weapon-wounding tests on dogs, cats, marine animals, ferrets and monkeys to study the health effects of the mysterious "Havana syndrome."

The Chinese Communist government erupts in fury over discussion of the probable origin of Covid-19 at the virus laboratory in Wuhan, China.

The Chinese Communist government erupts in fury over discussion of the probable origin of Covid-19 at the virus laboratory in Wuhan, China.